Picture of Redwood Pharma AB logo

REDW Redwood Pharma AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Redwood Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-15.5-14.5-20.5-13-13.5
Non-Cash Items0.545
Other Non-Cash Items
Changes in Working Capital-2.023.51-0.986-2.66-2.53
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-17.5-11-21.5-15.7-15.5
Capital Expenditures0-0.282-3.94
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00-0.0020
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities00-0.002-0.282-3.94
Net Issuance / Retirement of Stock
Cash from Financing Activities159.4529.712.412.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.53-1.568.19-3.54-6.97